home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Prescription Drug Labeling: Update from the FDA Perspective

 
  August 16, 2007  
     
 
Drug Information Association, Online
Oct 23 2007


On June 30, 2006, the FDA implemented new regulations for the new content and format of labeling. This webinar will provide a forum for FDA to reflect on its labeling experience over the past year and will include an opportunity for dialogue with FDA representatives concerning the new requirements.

WEBINAR HIGHLIGHTS
•Changes in the labeling review process related to the new content and format
•Challenges related to the implementation of the new content and format
•Updates regarding new FDA guidance documents that support the new regulations.

 
 
Organized by: Drug Information Association
Invited Speakers: Laurie Beth Burke, MPH, RPh
Director, Study Endpoints and Labeling Development Team, OND, CDER
FDA
United States.

Iris P. Masucci, PharmD
Labeling Reviewer, Division of Drug Marketing, Advertising & Comm., CDER
FDA
United States.

 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=14793&eventType=Webinar
E-mail: dia@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.